Impact of screening test performance and cost on mortality reduction and cost-effectiveness of multimodal ovarian cancer screening

Por Drescher, Charles W., Hawley, Sarah, Thorpe, Jason D., Marticke, Simone, McIntosh, Martin, Gambhir, Sanjiv, Urban, Nicole
Publicado em 2012

Dangerous Combinations: Ingestible CAM Supplement Use During Chemotherapy in Patients with Ovarian Cancer

Por Andersen, M. Robyn, Sweet, Erin, Lowe, Kimberly A., Standish, Leanna J., Drescher, Charles W., Goff, Barbara A.
Publicado em 2013

Involvement in decision-making about treatment and ovarian cancer survivor quality of life

Por Andersen, M. Robyn, Sweet, Erin, Lowe, Kimberly A., Standish, Leanna J., Drescher, Charles W., Goff, Barbara A.
Publicado no Gynecol Oncol (2011)

Extracting a low-dimensional description of multiple gene expression datasets reveals a potential driver for tumor-associated stroma in ovarian cancer

Por Celik, Safiye, Logsdon, Benjamin A., Battle, Stephanie, Drescher, Charles W., Rendi, Mara, Hawkins, R. David, Lee, Su-In
Publicado no Genome Med (2016)

Ultrasound Molecular Imaging in a Human CD276 Expression-Modulated Murine Ovarian Cancer Model

Por Lutz, Amelie M., Bachawal, Sunitha V., Drescher, Charles W., Pysz, Marybeth A., Willmann, Jürgen K., Gambhir, Sanjiv Sam
Publicado em 2014

Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors

Por Buas, Matthew F., Gu, Haiwei, Djukovic, Danijel, Zhu, Jiangjiang, Drescher, Charles W., Urban, Nicole, Raftery, Daniel, Li, Christopher I.
Publicado no Gynecol Oncol (2015)

Bead-based ELISA assays for validation of ovarian cancer early detection markers

Por Scholler, Nathalie, Crawford, Meghan, Sato, Alicia, Drescher, Charles W., O’Briant, Kathy C., Kiviat, Nancy, Anderson, Garnet L., Urban, Nicole
Publicado em 2006

Use of a Symptom Index, CA125 and HE4 to predict ovarian cancer

Por Andersen, M. Robyn, Goff, Barbara A., Lowe, Kimberly A., Scholler, Nathalie, Bergan, Lindsay, Drescher, Charles W., Paley, Pamela, Urban, Nicole
Publicado em 2009

Targeted single molecule mutation detection with massively parallel sequencing

Por Gregory, Mark T., Bertout, Jessica A., Ericson, Nolan G., Taylor, Sean D., Mukherjee, Rithun, Robins, Harlan S., Drescher, Charles W., Bielas, Jason H.
Publicado no Nucleic Acids Res (2016)

ESRRA-C11orf20 Is a Recurrent Gene Fusion in Serous Ovarian Carcinoma

Por Salzman, Julia, Marinelli, Robert J., Wang, Peter L., Green, Ann E., Nielsen, Julie S., Nelson, Brad H., Drescher, Charles W., Brown, Patrick O.
Publicado em 2011

Interpretation of single and serial measures of HE4 and CA125 in asymptomatic women at high risk for ovarian cancer

Por Urban, Nicole, Thorpe, Jason, Karlan, Beth Y., McIntosh, Martin W., Palomares, Melanie R., Daly, Mary B., Paley, Pamela, Drescher, Charles W.
Publicado em 2012

Longitudinal Screening Algorithm That Incorporates Change Over Time in CA125 Levels Identifies Ovarian Cancer Earlier Than a Single-Threshold Rule

Por Drescher, Charles W., Shah, Chirag, Thorpe, Jason, O'Briant, Kathy, Anderson, Garnet L., Berg, Christine D., Urban, Nicole, McIntosh, Martin W.
Publicado em 2013

Repertoire of microRNAs in Epithelial Ovarian Cancer as Determined by Next Generation Sequencing of Small RNA cDNA Libraries

Por Wyman, Stacia K., Parkin, Rachael K., Mitchell, Patrick S., Fritz, Brian R., O'Briant, Kathy, Godwin, Andrew K., Urban, Nicole, Drescher, Charles W., Knudsen, Beatrice S., Tewari, Muneesh
Publicado em 2009

High-throughput sequencing of T cell receptors reveals a homogeneous repertoire of tumor-infiltrating lymphocytes in ovarian cancer

Por Emerson, Ryan O., Sherwood, Anna M., Rieder, Mark J., Guenthoer, Jamie, Williamson, David W., Carlson, Christopher S., Drescher, Charles W., Tewari, Muneesh, Bielas, Jason H., Robins, Harlan S.
Publicado no J Pathol (2013)

Effects of Personal Characteristics on Serum CA125, Mesothelin, and HE4 Levels in Healthy Post-menopausal Women at High-Risk for Ovarian Cancer

Por Lowe, Kimberly A., Shah, Chirag, Wallace, Erin, Anderson, Garnet, Paley, Pamela, McIntosh, Martin, Andersen, M. Robyn, Scholler, Nathalie, Bergan, Lindsay, Thorpe, Jason, Urban, Nicole, Drescher, Charles W.
Publicado em 2008

DNA Methylation Profiles of Ovarian Epithelial Carcinoma Tumors and Cell Lines

Por Houshdaran, Sahar, Hawley, Sarah, Palmer, Chana, Campan, Mihaela, Olsen, Mari N., Ventura, Aviva P., Knudsen, Beatrice S., Drescher, Charles W., Urban, Nicole D., Brown, Patrick O., Laird, Peter W.
Publicado em 2010

Use of CA125 and HE4 serum markers to predict ovarian cancer in elevated-risk women

Por Karlan, Beth Y., Thorpe, Jason, Watabayashi, Kate, Drescher, Charles W., Palomares, Melanie, Daly, Mary B., Paley, Pam, Hillard, Paula, Andersen, M Robyn, Anderson, Garnet, Drapkin, Ronny, Urban, Nicole
Publicado em 2014

Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash

Por Schilder, Russell J., Pathak, Harsh B., Lokshin, Anna E., Holloway, Robert W., Alvarez, Ronald D., Aghajanian, Carol, Min, Hua, Devarajan, Karthik, Ross, Eric, Drescher, Charles W., Godwin, Andrew K.
Publicado em 2009

Effect of Referral for Genetic Counseling on Genetic Testing and Surgical Prevention in Women at High Risk for Ovarian Cancer-Results from a Randomized Controlled Trial

Por Drescher, Charles W., Beatty, J. David, Resta, Robert, Andersen, M Robyn, Watabayashi, Kate, Thorpe, Jason, Hawley, Sarah, Purkey, Hannah, Chubak, Jessica, Hanson, Nancy, Buist, Diana S.M., Urban, Nicole
Publicado no Cancer (2016)

INFLUENCE OF OVARIAN CANCER RISK STATUS ON THE DIAGNOSTIC PERFORMANCE OF THE SERUM BIOMARKERS MESOTHELIN, HE4 AND CA125

Por Shah, Chirag A., Lowe, Kimberly A., Paley, Pamela, Wallace, Erin, Anderson, Garnet L., McIntosh, Martin W., Andersen, M. Robyn, Scholler, Nathalie, Bergan, Lindsay A., Thorpe, Jason D., Urban, Nicole, Drescher, Charles W.
Publicado em 2009